利塞膦酸盐相关化合物C

C₇H₁₁NO₆P₂

267.11

9562253

MFCD26142887

Risedronate Related Compound C is an impurity of risedronate, belonging to the group of pyridinyl bisphosphonates, and is effectively used in the treatment of Paget′s disease of bone. It is also used for the treatment of skeletal disorders since it inhibits osteoclast-mediated bone resorption and modulates bone metabolism.

These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.
Risedronate may be used as a pharmaceutical reference standard for the quantification of the analyte in pharmaceutical formulations using reversed-phase ion-pair high-performance liquid chromatographic method.

These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

To see an example of a Certificate of Analysis for this material enter LRAB8927 in the Documents slot below. This is an example certificate only and may not be the lot that you receive.

certified reference material
pharmaceutical secondary standard

current certificate can be downloaded

pkg of 50 mg

neat

traceable to PhEur Y0001540
traceable to USP 1604643

2-30℃

OP(O)(C(CC1=CN=CC=C1)P(O)(O)=O)=O

1S/C7H11NO6P2/c9-15(10,11)7(16(12,13)14)4-6-2-1-3-8-5-6/h1-3,5,7H,4H2,(H2,9,10,11)(H2,12,13,14)

KZMOFWIRXNQJET-UHFFFAOYSA-N

GHS08

Warning

H361

P201 - P202 - P280 - P308 + P313 - P405 - P501

Repr. 2

13 - Non Combustible Solids

WGK 3